Berliner Boersenzeitung - US House votes for life-changing $35 insulin price cap

EUR -
AED 4.302187
AFN 82.240576
ALL 98.014932
AMD 450.215703
ANG 2.096473
AOA 1074.229379
ARS 1390.458805
AUD 1.794957
AWG 2.111558
AZN 1.986398
BAM 1.955042
BBD 2.364354
BDT 143.214481
BGN 1.954237
BHD 0.441966
BIF 3487.752139
BMD 1.171461
BND 1.494165
BOB 8.090933
BRL 6.415741
BSD 1.170981
BTN 100.132174
BWP 15.655399
BYN 3.832129
BYR 22960.633057
BZD 2.352108
CAD 1.600093
CDF 3370.292717
CHF 0.93646
CLF 0.028497
CLP 1093.535207
CNY 8.396855
CNH 8.402896
COP 4740.175836
CRC 590.588697
CUC 1.171461
CUP 31.043713
CVE 110.224152
CZK 24.742381
DJF 208.520945
DKK 7.459757
DOP 69.665075
DZD 151.575692
EGP 58.428834
ERN 17.571913
ETB 158.186228
FJD 2.626123
FKP 0.851846
GBP 0.854335
GEL 3.186072
GGP 0.851846
GHS 12.120405
GIP 0.851846
GMD 83.762821
GNF 10145.326864
GTQ 9.005509
GYD 244.877161
HKD 9.195868
HNL 30.597053
HRK 7.533695
HTG 153.515075
HUF 398.731887
IDR 19015.0357
ILS 3.96567
IMP 0.851846
INR 100.14046
IQD 1533.951177
IRR 49347.789387
ISK 142.016263
JEP 0.851846
JMD 187.657253
JOD 0.830535
JPY 169.631637
KES 151.41086
KGS 102.378595
KHR 4694.220305
KMF 492.277129
KPW 1054.339097
KRW 1594.275826
KWD 0.358279
KYD 0.975851
KZT 609.182045
LAK 25251.426561
LBP 104916.523557
LKR 351.166864
LRD 234.196208
LSL 20.969571
LTL 3.45902
LVL 0.708605
LYD 6.341596
MAD 10.572672
MDL 19.830905
MGA 5148.048248
MKD 61.506407
MMK 2459.273973
MNT 4199.742503
MOP 9.469012
MRU 46.698296
MUR 52.903306
MVR 18.04638
MWK 2030.430214
MXN 22.08424
MYR 4.953523
MZN 74.926473
NAD 20.970197
NGN 1808.498157
NIO 43.093294
NOK 11.810932
NPR 160.211679
NZD 1.934556
OMR 0.450428
PAB 1.170956
PEN 4.156189
PGK 4.83021
PHP 66.401957
PKR 332.108889
PLN 4.242623
PYG 9344.377549
QAR 4.268346
RON 5.084491
RSD 117.180049
RUB 91.959326
RWF 1690.895025
SAR 4.393685
SBD 9.77858
SCR 16.509221
SDG 703.466562
SEK 11.114447
SGD 1.495423
SHP 0.920584
SLE 26.353857
SLL 24564.953012
SOS 669.160585
SRD 44.05397
STD 24246.874845
SVC 10.24629
SYP 15230.957666
SZL 20.965499
THB 38.193114
TJS 11.545523
TMT 4.111828
TND 3.423173
TOP 2.743676
TRY 46.723127
TTD 7.947987
TWD 34.081267
TZS 3089.244203
UAH 48.822107
UGX 4209.440031
USD 1.171461
UYU 47.172518
UZS 14738.412304
VES 124.384028
VND 30569.27141
VUV 140.724989
WST 3.217372
XAF 655.708405
XAG 0.032426
XAU 0.000358
XCD 3.165932
XDR 0.817419
XOF 655.733584
XPF 119.331742
YER 283.786449
ZAR 20.881782
ZMK 10544.553772
ZMW 27.72249
ZWL 377.209922
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

US House votes for life-changing $35 insulin price cap
US House votes for life-changing $35 insulin price cap

US House votes for life-changing $35 insulin price cap

US lawmakers voted Thursday on a bill limiting the cost of insulin to $35 a month, a transformative curb for millions of diabetics who pay hundreds of dollars for the life-sustaining hormone.

Text size:

Drug pricing has vexed politicians for years in the United States, which has the highest annual health expenditure of any industrialized country, at around $11,000 per capita.

Insulin costs the 7.4 million American adults who use it to manage their diabetes eight times as much as in other wealthy nations, according to a 2020 study commissioned by the Health and Human Services Department.

"This is a kitchen table issue: are people going to be able to pay their bills? And it is, for us, a step in the direction of the (government) being able to negotiate for lower drug prices beyond insulin," House Speaker Nancy Pelosi told reporters.

The legislation passed the House of Representatives by 232 votes to 193, with a handful of Republicans crossing the aisle to join the Democrats, and now advances to the upper chamber of Congress, the US Senate.

It would require private health insurance companies to set prices for a month's supply of insulin at no more than $35, or 25 percent of a plan's negotiated price, whichever is lower, starting in 2023 for some patients and 2024 for all.

The cap was a provision in President Joe Biden's "Build Back Better" social welfare bill that was torpedoed by Democratic infighting in Congress late last year.

Biden brought the issue back into the spotlight during his State of the Union address on March 1, reinvigorating calls for action on pricing from diabetes advocates.

The effort is being seen as the only way for Democrats to show they're capable of acting on sky-high prescription drug prices before November's midterm elections.

- 'Costing a lot' -

The Senate is holding its own cross-party negotiations on driving down insulin costs by targeting the middlemen between health insurance companies and pharmacies.

And a separate Democrat-only bill from Georgia's Senator Raphael Warnock that would also cap the price at $35 is likely to be combined with the effort.

"I'm a pastor -- I'm on the ground -- and so I know that everybody knows somebody with diabetes," Warnock said in a video promoting his initiative.

Senate Majority Leader Chuck Schumer told reporters last week he believed a bipartisan bill had a good chance of passing when lawmakers return from a break at the end of April.

Research suggests that more than a quarter of Americans with type 1 diabetes have had to ration insulin they could not afford. Campaigners say the proportion went up to 50 percent during the pandemic.

It remains unclear if any legislation can gain the 10 Republican votes needed to advance in the Senate, but some opposition lawmakers have shown interest in an issue that affects voters across the board.

"I'd be for some kind of regulation where we can help. Too many people (are) paying thousands of dollars a month. I'm not big on regulating process, but that one's costing a lot of people a lot of money," Alabama Senator Tommy Tuberville told Axios.

Republicans on the powerful House Ways and Means Committee described the vote as "the largest expansion of federal command and control in Americans' private health insurance design" since the Affordable Care Act, the landmark 2010 regulatory overhaul and expansion of health care coverage.

"Democrats are reviving their socialist drug pricing scheme from their failed radical tax and spending spree," the committee's top Republican Kevin Brady said in a statement.

(Y.Berger--BBZ)